Document is current
Any future updates will be listed below
-
Authors
Abraham, Edward H. https://orcid.org/0000-0002-4429-2389
Guidotti, Guido
Rapaport, Eliezer
Bower, David
Brown, Jack
Griffin, Robert J.
Donnelly, Andrew
Waitzkin, Ellen D.
Qamar, Kenon
Thompson, Mark A.
Ethirajan, Sukumar
Robinson, Kent
- License Information
-
More Information
Article History
Received: 16 June 2020
Accepted: 26 January 2021
First Online: 10 May 2021
Declarations
:
: The clinical trial described in this study was evaluated and granted exempt status by Solutions IRB. All documents generated as a result of this evaluation have been published online and any that are requested will be made available to the reviewers of this manuscript.Informed consent was obtained from all patients who participated in this trial. The consent forms were thoroughly examined by Solutions IRB as part of their evaluation of the clinical trial described in this paper.
: Edward H. Abraham: Owns intellectual property in the form of various patents for ATP use.Guido Guidotti: No competing interests.Eliezer Rapaport: Owns intellectual property in the form of various patents for ATP use.David M. Bower: No competing interests.Jack Brown: No competing interests.Andrew Donnelly: No competing interestsRobert J. Griffin: No competing interests.Ellen D. Waitzkin: No competing interests.Kenon Qamar: No competing interests.Mark A. Thompson: No competing interests.Sukumar Ethirajan: No competing interests.Kent Robinson: No competing interest.
